{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:31:27Z","timestamp":1763141487264,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To date, there are only a few case reports of cyclophosphamide (Cy)-induced hemorrhagic cystitis (HC) in adult or pediatric allogeneic stem cell transplant (SCT) patients treated successfully with hyperbaric oxygen (HBO). In all the reported cases, Cy was used as a part of the conditioning regimen, rather than post-transplant for graft-versus-host-disease (GVHD) prophylaxis. More recently, the risk of HC in allogeneic SCT is further increased by the widespread use of post-transplantation cyclophosphamide (PTCy) as a highly effective strategy for GVHD prophylaxis. This is the first case reported of PTCy-induced HC successfully treated with HBO to the best of our knowledge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>In this article, we present a 58-year-old Caucasian male case of allogeneic SCT complicated by severe HC following PTCy, which was successfully treated with HBO, eliminating the need for cystectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HBO can be a safe, noninvasive, alternative treatment modality for PTCy-induced HC developing in allogeneic SCT patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-020-02580-w","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T13:03:10Z","timestamp":1609765390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the\u00a0literature"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-2380","authenticated-orcid":false,"given":"Moayed","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshama","family":"Bhyravabhotla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Van Meter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakhle S.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Safah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Socola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"11","key":"2580_CR1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/bmt.2015.162","volume":"50","author":"LE Lunde","year":"2015","unstructured":"Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant. 2015;50(11):1432\u20137.","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"2580_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3324\/haematol.2016.151779","volume":"102","author":"A Ruggeri","year":"2017","unstructured":"Ruggeri A, Sun Y, Labopin M, Bacigalupo A, Lorentino F, Arcese W, et al. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. Haematologica. 2017;102(2):401\u201310.","journal-title":"Haematologica"},{"issue":"3","key":"2580_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/01.ju.0000080563.58561.c8","volume":"170","author":"S Kalayoglu-Besisik","year":"2003","unstructured":"Kalayoglu-Besisik S, Abdul-Rahman IS, Erer B, Yenerel MN, Oguz FS, Tunc M, et al. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis. J Urol. 2003;170(3):922.","journal-title":"J Urol."},{"issue":"12","key":"2580_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.bmt.1703077","volume":"27","author":"K Hattori","year":"2001","unstructured":"Hattori K, Yabe M, Matsumoto M, Kudo Y, Yasuda Y, Inoue H, et al. Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27(12):1315\u20137.","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"2580_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.bmt.1704252","volume":"32","author":"S Cesaro","year":"2003","unstructured":"Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant. 2003;32(9):925\u201331.","journal-title":"Bone Marrow Transplant."},{"key":"2580_CR6","first-page":"32","volume":"6","author":"M Payandeh","year":"2018","unstructured":"Payandeh M, Ghorbani S, Karami A, Veisi N, Ghasemi A, Maadikhah M, et al. Hyperbaric oxygen therapy for hemorrhagic cystitis after the allogeneic stem cell transplantation-a case report. Am J Cancer Prev. 2018;6:32\u20134.","journal-title":"Am J Cancer Prev."},{"issue":"1","key":"2580_CR7","first-page":"13","volume":"11","author":"SA Mousavi","year":"2017","unstructured":"Mousavi SA, Moazed V, Mohebbi N, Hadjibabaie M, Alimoghaddam K, Bahar B, et al. Conjugated estrogen in late-onset hemorrhagic cystitis associated with hematopoietic stem cell transplantation. Int J Hematol Oncol Stem Cell Res. 2017;11(1):13\u20138.","journal-title":"Int J Hematol Oncol Stem Cell Res."},{"issue":"3","key":"2580_CR8","first-page":"247","volume":"41","author":"EM Camporesi","year":"2014","unstructured":"Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41(3):247\u201352.","journal-title":"Undersea Hyperb Med."},{"issue":"7166","key":"2580_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/bmj.317.7166.1140","volume":"317","author":"RM Leach","year":"1998","unstructured":"Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ. 1998;317(7166):1140\u20133.","journal-title":"BMJ"},{"issue":"1","key":"2580_CR10","first-page":"21","volume":"43","author":"A Hadanny","year":"2016","unstructured":"Hadanny A, Meir O, Bechor Y, Fishlev G, Bergan J, Efrati S. Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions. Undersea Hyperb Med. 2016;43(1):21\u20138.","journal-title":"Undersea Hyperb Med."},{"issue":"1","key":"2580_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0738-081X(94)90265-8","volume":"12","author":"RN Roth","year":"1994","unstructured":"Roth RN, Weiss LD. Hyperbaric oxygen and wound healing. Clin Dermatol. 1994;12(1):141\u201356.","journal-title":"Clin Dermatol."},{"issue":"1","key":"2580_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","volume":"12","author":"WP Brade","year":"1985","unstructured":"Brade WP, Herdrich K, Varini M. Ifosfamide\u2013pharmacology, safety and therapeutic potential. Cancer Treat Rev. 1985;12(1):1\u201347.","journal-title":"Cancer Treat Rev."},{"issue":"12","key":"2580_CR13","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1200\/JCO.2002.04.178","volume":"20","author":"LM Schuchter","year":"2002","unstructured":"Schuchter LM, Hensley ML, Meropol NJ, Winer EP, American Society of Clinical Oncology C, Radiotherapy Expert P. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2002;20(12):2895\u2013903.","journal-title":"J Clin Oncol."},{"issue":"11","key":"2580_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1200\/JCO.1991.9.11.2016","volume":"9","author":"JD Shepherd","year":"1991","unstructured":"Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9(11):2016\u201320.","journal-title":"J Clin Oncol."},{"issue":"3","key":"2580_CR15","first-page":"199","volume":"2","author":"S Haldar","year":"2014","unstructured":"Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014;2(3):199\u2013208.","journal-title":"Am J Clin Exp Urol."},{"issue":"2","key":"2580_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0970-1591.65380","volume":"26","author":"R Manikandan","year":"2010","unstructured":"Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol. 2010;26(2):159\u201366.","journal-title":"Indian J Urol."},{"issue":"4","key":"2580_CR17","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","volume":"74","author":"LM Schuchter","year":"1989","unstructured":"Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood. 1989;74(4):1424\u20137.","journal-title":"Blood"},{"issue":"2","key":"2580_CR18","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.4081\/hr.2017.7205","volume":"9","author":"D Mert","year":"2017","unstructured":"Mert D, Batgi H, Merdin A, \u00c7eken S, Dal MS, Tekg\u00fcnd\u00fcz E, et al. BK virus-associated hemorrhagic cystitis in patients with allogeneic hematopoietic cell transplantation: report of three cases. Hematol Rep. 2017;9(2):7205.","journal-title":"Hematol Rep."},{"issue":"25","key":"2580_CR19","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1182\/blood-2014-07-587477","volume":"124","author":"CG Kanakry","year":"2014","unstructured":"Kanakry CG, Tsai HL, Bolanos-Meade J, Smith BD, Gojo I, Kanakry JA, et al. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 2014;124(25):3817\u201327.","journal-title":"Blood"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02580-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T11:20:51Z","timestamp":1670671251000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02580-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2580"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02580-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}